BRIEF-Lexicon Pharmaceuticals gets European Commission's approval for Xermelo
September 19, 2017 at 12:54 PM EDT
* European Commission approves Xermelo (Telotristat Ethyl) for the treatment of Carcinoid Syndrome Diarrhea in combination with somatostatin analog therapy
